Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05711108 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
A clinical trial, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- 86
- Enrollment target
NCT05711108 is a clinical trial that has completed, run by Joslin Diabetes Center. The registered enrollment target is 86 participants.
The verdict
NCT05711108 has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications). This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2022-01-19 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05711108
The ClinicalTrials.gov registry entry for NCT05711108 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05711108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05711108 about?
NCT05711108 is a clinical study titled "Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities". To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing faci...
What is the current status of trial NCT05711108?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2022-01-19. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT05711108?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.